Long-term entecavir therapy results in falls in serum hepatitis B surface antigen levels and seroclearance in nucleos(t)ide-naïve chronic hepatitis B patients. (Q41719578)

From Wikidata

Jump to navigation Jump to search

scientific article published on 16 December 2013

Language	Label	Description	Also known as
English	Long-term entecavir therapy results in falls in serum hepatitis B surface antigen levels and seroclearance in nucleos(t)ide-naïve chronic hepatitis B patients.	scientific article published on 16 December 2013

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25274427%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Long-term entecavir therapy results in falls in serum hepatitis B surface antigen levels and seroclearance in nucleos(t)ide-naïve chronic hepatitis B patients (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25274427%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

chronic hepatitis B

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25274427%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

author name string

T Hara

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25274427%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

F Suzuki

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25274427%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Y Kawamura

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25274427%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

H Sezaki

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25274427%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

N Akuta

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25274427%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

M Kobayashi

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25274427%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Y Suzuki

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25274427%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

S Saitoh

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25274427%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Y Arase

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25274427%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

K Ikeda

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25274427%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

M Kobayashi

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25274427%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

S Watahiki

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25274427%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

R Mineta

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25274427%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

H Kumada

15

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25274427%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

publication date

16 December 2013

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25274427%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Journal of Viral Hepatitis

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25274427%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

21

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25274427%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

802-808

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25274427%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25274427%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12211

21 January 2018

Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12211

21 January 2018

Long-term use of entecavir in nucleoside-naïve Japanese patients with chronic hepatitis B infection

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12211

21 January 2018

Entecavir treatment for up to 5 years in patients with hepatitis B e antigen-positive chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12211

21 January 2018

Quantitative hepatitis B surface antigen and hepatitis B e antigen titers in prediction of treatment response to entecavir.

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12211

21 January 2018

Loss of HBsAg antigen during treatment with entecavir or lamivudine in nucleoside-naïve HBeAg-positive patients with chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12211

21 January 2018

Three-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12211

21 January 2018

2-Year GLOBE trial results: telbivudine Is superior to lamivudine in patients with chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12211

21 January 2018

Clearance of hepatitis B surface antigen during long-term nucleot(s)ide analog treatment in chronic hepatitis B: results from a nine-year longitudinal study

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12211

21 January 2018

Hepatitis B virus surface antigen levels: a guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12211

21 January 2018

Serological detection of hepatitis B virus genotypes by ELISA with monoclonal antibodies to type-specific epitopes in the preS2-region product

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12211

21 January 2018

Classification of hepatitis B virus genotypes by the PCR-Invader method with genotype-specific probes

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12211

21 January 2018

A large case-control study on the predictability of hepatitis B surface antigen levels three years before hepatitis B surface antigen seroclearance.

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12211

21 January 2018

Serum hepatitis B surface antigen and hepatitis B e antigen titers: disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12211

21 January 2018

Hepatitis B surface antigen (HBsAg) decrease and serum interferon-inducible protein-10 levels as predictive markers for HBsAg loss during treatment with nucleoside/nucleotide analogues.

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12211

21 January 2018

Early serum HBsAg drop: A strong predictor of sustained virological response to pegylated interferon alfa-2a in HBeAg-negative patients

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12211

21 January 2018

Quantitative Hepatitis B Surface Antigen Levels in Patients With Chronic Hepatitis B After 2 Years of Entecavir Treatment

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12211

21 January 2018

Reduction of hepatitis B surface antigen levels and hepatitis B surface antigen seroclearance in chronic hepatitis B patients receiving 10 years of nucleoside analogue therapy

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12211

21 January 2018

Kinetics of hepatitis B surface antigen differ between treatment with peginterferon and entecavir

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12211

21 January 2018

Identifiers

10.1111/JVH.12211

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25274427%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

release_xw7evpulh5gjpbrjlwp7srf7l4

1 reference

https://api.fatcat.wiki/v0/release/xw7evpulh5gjpbrjlwp7srf7l4

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25274427%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41719578&oldid=1843511551"